NCT07089823

A Study of YP05002 in Healthy Participants

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YP05002 in Healthy Participants

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 76 (estimated)
• Sponsor: Yaopharma Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants

Conditions

• Weight Management

Interventions

Type	Name	Description
DRUG	YP05002	Tablet, QD
OTHER	Placebo	Tablet, QD

Timeline

• Start date: 2025-08-19
• Primary completion: 2026-04-12
• Completion: 2026-06-30
• First posted: 2025-07-28
• Last updated: 2025-08-06

Locations

1 site across 1 country: Australia